A report in the Economic Times says that the regulator has sent letters to over 300 firms, which are looking to get approvals for fixed dose combination (FDC) drugs.
After banning 344 combination drugs earlier this year, the government is once again targeting another 500 combination drugs.
FDC drugs are those that which contains combination of two or more active pharmaceutical ingredients (APIs) in a single form, which is usually manufactured and distributed in fixed dose. Earlier, these drugs used to be for a single disease, but are now available for multiple diseases.
